FdaApplication
ANDA 218798
Identifiers
- fda_app_no: ANDA218798
Properties
| Property | Value |
|---|---|
| applicant_name | SOMERSET THERAPEUTICS LLC |
| application_type | ANDA |
| approval_date | 2026-01-29 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RILPIVIRINE | RILPIVIRINE | 2.5MG | TABLET |
| RILPIVIRINE HYDROCHLORIDE | RILPIVIRINE HYDROCHLORIDE | EQ 25MG BASE | TABLET;ORAL |
2 products